News

Study Connects Herpes to Biological Risk for Alzheimer’s

A biological framework called the “microcompetition model” may explain why people infected with herpes simplex 1 (HSV1) are at increased risk of developing Alzheimer’s disease. “These dynamics explain the observed connection reported in many studies between the virus and Alzheimer’s disease, and provide a framework for further investigations,” researchers…

Mouse Study: 4 Approved Meds Are Potential Alzheimer’s Treatments

Detailed molecular signatures in three mouse models of Alzheimer’s disease at different disease stages allowed for identification of four approved medicines that may be potential Alzheimer’s treatments, a study revealed. The four medications that demonstrated efficiency are now used to treat hypertension (high blood pressure) and inflammation in humans.

2 Trials Testing Oral Varoglutamstat Now Enrolling in US, Europe

Vivoryon Therapeutics is looking to enroll patients at different stages of Alzheimer’s disease for two ongoing, Phase 2 trials evaluating the safety and efficacy of its investigational oral treatment varoglutamstat. The therapy candidate has shown evidence, in earlier trials, of improving cognition, memory, and attention in Alzheimer’s patients, with…

Many Ways to Mark National Alzheimer’s Disease Awareness Month

Every November since President Ronald Reagan’s proclamation in 1983, Americans have been partaking in National Alzheimer’s Disease Awareness Month. These next 30 days will be an opportunity for people to honor the progress made toward understanding and treating the disease while raising money for research and care. It also…